Lonza Group AG (SWX:LONN)
Switzerland
· Delayed Price · Currency is CHF 599.80
+11.20 (1.90%)
May 2, 2025, 5:30 PM CET
Revenue by Product
Financial numbers in millions CHF.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Biologics | 3,676 |
Log In |
Log In |
Log In |
Log In |
| Biologics Growth | 23.81% |
Log In |
Log In |
Log In |
Log In |
| Small Molecules | 983 |
Log In |
Log In |
Log In |
Log In |
| Small Molecules Growth | 18.79% |
Log In |
Log In |
Log In |
Log In |
| Cell & Gene | 689 |
Log In |
Log In |
Log In |
Log In |
| Cell & Gene Growth | 6.95% |
Log In |
Log In |
Log In |
Log In |
| Capsules & Health Ingredients | 1,054 |
Log In |
Log In |
Log In |
Log In |
| Capsules & Health Ingredients Growth | -10.32% |
Log In |
Log In |
Log In |
Log In |
| Corporate | 172 |
Log In |
Log In |
Log In |
Log In |
| Corporate Growth | 33.77% |
Log In |
Log In |
Log In |
Log In |
EBITDA by Product
Financial numbers in millions CHF.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Biologics Core EBITDA | 1,266 |
Log In |
Log In |
Log In |
Log In |
| Biologics Core EBITDA Growth | 16.99% |
Log In |
Log In |
Log In |
Log In |
| Small Molecules Core EBITDA | 351 |
Log In |
Log In |
Log In |
Log In |
| Small Molecules Core EBITDA Growth | 38.66% |
Log In |
Log In |
Log In |
Log In |
| Cell & Gene Core EBITDA | 108 |
Log In |
Log In |
Log In |
Log In |
| Cell & Gene Core EBITDA Growth | -20.72% |
Log In |
Log In |
Log In |
Log In |
| Capsules & Health Ingredients Core EBITDA | 256 |
Log In |
Log In |
Log In |
Log In |
| Capsules & Health Ingredients Core EBITDA Growth | -29.33% |
Log In |
Log In |
Log In |
Log In |
| Corporate Core EBITDA | -73 |
Log In |
Log In |
Log In |
Log In |
| Corporate Core EBITDA Growth | 26.56% |
Log In |
Log In |
Log In |
Log In |
Revenue by Geography
Financial numbers in millions CHF.
Year Ending | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 |
|---|---|---|---|---|---|
| Europe | 3,144 |
Log In |
Log In |
Log In |
Log In |
| Europe Growth | - |
Log In |
Log In |
Log In |
Log In |
| North and Central America | 2,444 |
Log In |
Log In |
Log In |
Log In |
| North and Central America Growth | - |
Log In |
Log In |
Log In |
Log In |
| Latin America | 129 |
Log In |
Log In |
Log In |
Log In |
| Latin America Growth | - |
Log In |
Log In |
Log In |
Log In |
| Asia | 837 |
Log In |
Log In |
Log In |
Log In |
| Asia Growth | - |
Log In |
Log In |
Log In |
Log In |
| Australia & New Zealand | 17 |
Log In |
Log In |
Log In |
Log In |
| Australia & New Zealand Growth | - |
Log In |
Log In |
Log In |
Log In |
| Other Geographic | 3 |
Log In |
Log In |
Log In |
Log In |
| Other Geographic Growth | - |
Log In |
Log In |
Log In |
Log In |